Pharmacology of Antiviral Drugs, 2nd Edition
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Viral Immunology, Vaccines, and Antivirals".
Deadline for manuscript submissions: 28 February 2026 | Viewed by 427
Special Issue Editor
Interests: antiviral; influenza virus; repurposed; respiratory syncytial virus (RSV); respiratory virus; RSV; SARS-CoV-2; therapeutic
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Viral infections cause significant morbidity and mortality across the globe in both humans and animals. As the world emerges from the latest viral pandemic, it is clear that considerable work remains to identify and characterize new antiviral treatments. We therefore invite submissions for our upcoming Special Issue on the pharmacology of antiviral drugs. This special issue aims to explore and elucidate the intricate pharmacological aspects of antiviral medications. Researchers and experts are encouraged to contribute original research articles, reviews, and short communications that delve into various aspects of antiviral pharmacology. We welcome submissions that cover a wide range of topics, including, but not limited to, molecular interactions between drugs and viral targets, pharmacokinetics, pharmacodynamics, and the influence of host factors on drug efficacy. Additionally, we seek contributions addressing emerging topics such as drug resistance, novel drug delivery approaches, and advancements in medicinal chemistry to optimize antiviral treatment strategies in humans and animals.
Join us in advancing our understanding of antiviral pharmacology and shaping the future of antiviral therapy. Submit your contributions to this Special Issue to contribute to the global effort in combating viral infections and improving public health outcomes.
Dr. David E. Martin
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pharmacology
- clinical pharmacology
- antiviral therapy
- antiviral prophylaxis
- human viruses
- animal viruses
- pharmacokinetics
- pharmacodynamics
- drug resistance
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
